Territory Stories

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Details:

Title

NT trends in ecstasy and related drug markets 2011 : findings from the Ecstasy and Related Drugs Reporting System (EDRS)

Collection

NT trends in ecstasy and related drug markets; Reports; PublicationNT

Date

2011

Description

Made available via the Publications (Legal Deposit) Act 2004 (NT).

Notes

Date:2011; Australian drug trends series No. 80

Language

English

Subject

Drug abuse surveys -- Northern Territory -- Periodicals; Ecstasy (Drug) -- Northern Territory -- Periodicals; Drug abuse -- Northern Territory -- Periodicals

Publisher name

National Drug and Alcohol Research Centre, University of New South Wales

Place of publication

Sydney (N.S.W)

ISBN

9780733430206

Copyright owner

Check within Publication or with content Publisher.

Parent handle

https://hdl.handle.net/10070/242182

Citation address

https://hdl.handle.net/10070/610318

Page content

22 Table 12: Frequency of methadone use in previous six months, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Illicit methadone syrup No recent use 70 78 86 92 88 Weekly or less 22 18 11 7 7 More than weekly 9 3 1 1 2 Daily 0 1 1 0 0 Illicit physeptone No recent use 76 70 79 75 74 Weekly or less 23 27 17 18 26 More than weekly 1 2 2 6 0 Daily 0 1 1 1 0 Source: IDRS participant interviews 4.6.2 Morphine Recent use of morphine decreased to 81%, of the sample, a similar level to that seen between 2005 and 2007 (Table 13). Median days of use remained stable (daily) and there was an increase in median days injected (from 155 days in 2010 to 180 days in 2011). Table 13: Selected trends in participants morphine use, 2007-2011 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Used last 6 months (%) 82 89 70 91 81 Injected last 6 months (%) 76 87 70 91 78 Days used last 6 months (median) 180 133 180 180 180 Days injected last 6 months (median) 180 130 120 155 180 Source: IDRS participant interviews Illicit morphine continued to be the form most often used; however, while almost three quarters of the sample had recently used illicit morphine, this is a reduction from the 89% who reported recent use of illicit morphine in 2010 (Table 14). Use of licit morphine increased from 24% of the sample in 2010 to 28% in 2011. MS Contin was again the brand most frequently used (79%) followed by Kapanol (13%). Table 14: Forms and brands of morphine used previous six months, 2007-2011 (%) 2007 N=106 2008 N=103 2009 N=99 2010 N=99 2011 N=98 Used Most often Used Most often* Used Most often Used Most often Used Most often Licit 33 14 19 16 26 26 24 16 28 18 Illicit 73 37 85 73 61 43 89 73 73 60 Brand MS Contin 59 81 52 81 79 Kapanol 8 12 13 9 13 Anamorph 1 3 3 1 0 Other/generic 9 2 1 8 3 Source: IDRS participant interviews * Data missing on some records


Aboriginal and Torres Strait Islander people are advised that this website may contain the names, voices and images of people who have died, as well as other culturally sensitive content. Please be aware that some collection items may use outdated phrases or words which reflect the attitude of the creator at the time, and are now considered offensive.

We use temporary cookies on this site to provide functionality.
By continuing to use this site without changing your settings, you consent to our use of cookies.